Study Stopped
Decision after interims analysis
Hartmanns Procedure or Abdominoperineal Excision With Intersphincteric Dissection in Rectal Cancer: a Randomized Study
HAPIrect
1 other identifier
interventional
164
1 country
1
Brief Summary
In patients with rectal cancer, an anterior resection with a colo-rectal or colo-anal anastomoses is the gold standard. However, in patients with a weak sphincter and fecal incontinence or in patients with severe co-morbidity and reduced general condition, this operation is not suitable. In these situations there are two other radical surgical options, Hartmanns procedure and the Abdominoperineal excision that can be performed with intersphincteric dissection to minimise perineal complications.There are no data on which of these procedures that are best suited for these patients with fecal incontinence or severe co-morbidity( at risk for life-threatening anastomotic leak). In this randomized study we intend to compare postoperative complications within 30 days after these two procedures and also late complications and quality of life after one year postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2013
CompletedFirst Posted
Study publicly available on registry
November 26, 2013
CompletedStudy Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedDecember 16, 2021
December 1, 2021
7.8 years
November 21, 2013
December 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rates ot postoperative surgical complications within 30 days.
Perineal and abdominal wound infection, pelvic abscess urinary catheter at discharge etc
30 days
Secondary Outcomes (7)
Peroperative data
day of surgery
The rate of intraoperative perforations
day of surgery
Resection margins
2-4 weeks after surgery
Rate of local recurrence
3 and 5 years postoperatively
Survival after 3 and 5 years follow-up
3 and 5 years postoperativelly
- +2 more secondary outcomes
Other Outcomes (2)
quality of life between the two methods
Preoperative and one year after surgery
Late complications after surgery
One year postoperativelly
Study Arms (2)
APE with intersphincteric dissection
ACTIVE COMPARATORAbdominoperineal excision with intersphincteric dissection and a stoma is performed in patients with rectal cancer and fecal incontinence and/or severe co-morbidity
Hartmann´s procedure
ACTIVE COMPARATORHartmann´s operation and stoma is performed in patients with rectal cancer and fecal incontinence and/or severe co-morbidity
Interventions
Abdominal operation where the rectum is resected down to the levator and then the anus is resected by an intersphincteric dissection and order to leave the outer sfincter and levator in place to avoid a large wound and a high rate of infectious complications.
Abdominal operation where the rectum is resected and stapled off distally and a stoma is created
Eligibility Criteria
You may qualify if:
- Rectal cancer 5cm or more from the anal verge
- Both procedures should be possible to perform
- Patients should have co-morbidities and/or have weak anal sphincter where an anterior resection is not suitable
- Metastases are no contraindication but the procedure should be assessed as locally radical.
- Patients should be assesed to cope with a major abdominal procedure(ASA I-III)
You may not qualify if:
- rectal cancer below 5cm from the anal verge where a Hartmann is considered not to be locally radical.
- patients where an anterior resection is suitable
- ASA IV or worse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Västmanlands Hospital Västerås
Västerås, 72189, Sweden
Related Publications (2)
Nikberg M, Akerlund V, Swartling T, Buchwald P, Smedh K; HAPIrect Collaborative Study Group. Postoperative complications in Hartmann's procedure versus intersphincteric abdominoperineal excision in rectal cancer: randomized clinical trial (HAPIrect). BJS Open. 2025 Sep 8;9(5):zraf093. doi: 10.1093/bjsopen/zraf093.
PMID: 41026509DERIVEDSmedh K, Sverrisson I, Chabok A, Nikberg M; HAPIrect Collaborative Study Group. Hartmann's procedure vs abdominoperineal resection with intersphincteric dissection in patients with rectal cancer: a randomized multicentre trial (HAPIrect). BMC Surg. 2016 Jul 11;16(1):43. doi: 10.1186/s12893-016-0161-2.
PMID: 27401339DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth Smedh, PhD
Region Vastmanland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 21, 2013
First Posted
November 26, 2013
Study Start
February 1, 2014
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
December 16, 2021
Record last verified: 2021-12